Abstract
The effects of cytokine and fatty acid treatment on signal transduction in dermal fibroblasts from type 1 diabetics and matched controls were compared. Chronic exposure to TNF, accentuated Ca2+ mobilization in response to bradykinin (BK) in cells from both controls and diabetics; responses were three-fold greater in cells from diabetics than in controls. Similarly, with chronic exposure to IL-1β, BK-induced Ca2+ mobilization was accentuated in cells from type 1 diabetics compared to the controls. Pretreatment with the protein synthesis inhibitor cycloheximide or the protein kinase C inhibitor calphostin C prior to the addition of TNF completely abrogated the TNF-induced increment in peak bradykinin response. Ca2+ transients induced by depleting endoplasmic reticulum (ER) Ca2+ with thapsigargin were also greater in TNF treated fibroblasts than in untreated cells, with greater increases in cells from diabetics. Exposing fibroblasts for 48 hours to 2 mM oleate also increased both the peak bradykinin response and the TNF-induced increment in peak response, which were significantly greater in diabetics than controls. These data indicate that cells from diabetic patients acquire elevated ER Ca2+ stores in response to both cytokines and free fatty acids,and thus exhibit greater sensitivity to environmental inflammatory stimuli and elevated lipids.
Highlights
The inflammatory cytokines tumor necrosis factor-alpha (TNFa) and interleukin-1b (IL-1b) are implicated in both type 1 and type 2 diabetes [1]
These illustrations suggest that the enhanced cytokine sensitivity observed in diabetic fibroblast responses may not be limited to treated (0.6 nM for 24 hours) fibroblasts were exposed to 200 nM BK
Human skin fibroblasts from type 1 diabetic subjects exhibit several distinguishing features that differentiate them from control fibroblasts
Summary
The inflammatory cytokines tumor necrosis factor-alpha (TNFa) and interleukin-1b (IL-1b) are implicated in both type 1 and type 2 diabetes [1]. Our data show a significant differences between control and type 1 diabetic fibroblasts in Ca2+ signaling following FFA treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.